Olian Judy D. 4

What Happened
Judy D. Olian, a director of United Therapeutics (UTHR), sold 200 shares of common stock on March 16, 2026 at $535.44 per share, generating proceeds of $107,088. This was a sale (S), not a purchase — sales are often routine and do not necessarily indicate a change in the insider’s view of the company.

Key Details

• Transaction date and price: 2026-03-16 at $535.44 per share.
• Shares sold / value: 200 shares; proceeds $107,088 (disposed).
• Transaction type: Open market/private sale (code S).
• Shares owned after transaction: Not reported in the provided excerpt.
• Footnote: Sale executed pursuant to a pre-arranged 10b5-1 trading plan established Nov 24, 2025 (per F1).
• Filing timeliness: Report dated and filed 2026-03-16 (same-day filing; not marked late).

Context
A 10b5-1 plan means the trade was pre-scheduled and is generally considered routine; such sales under these plans are less indicative of new insider information. For retail investors, purchases often carry more weight as bullish signals; routine insider sales are common for diversification or liquidity needs.